Powder Delivery TRIZ Cases

Functionalized nanoparticles enable photoacoustic detection of biomarkers in the retina, resolving early metastasis visibility limits.

Polymeric nanoparticles with bone-affinity ligands deliver therapeutic agents to surgical implants.

Biofunctionalized Prussian blue nanocomposites deliver latency reversing agents and antibodies to target cells.

A crystalline compound of tiotropium bromide and propionic acid forms a stable matrix for inhalation.

Nanoparticle carriers enhance urolithin A bioavailability, reducing dose frequency while treating acute kidney injury.

Angular drug particles breach the stratum corneum to enable efficient transdermal delivery, avoiding costly microneedle manufacturing.

Hydroxyapatite coatings on bioresorbable screws enable targeted BMP-2 delivery, enhancing graft-bone healing while reducing tunnel widening.

Jet milling creates a specific particle size distribution that minimizes cardiac side effects from systemic exposure.

Polycation-mediated encapsulation extends plasma half-life and tumor accumulation while maintaining radiosensitizing properties.

NTS-polyplex nanoparticles deliver therapeutic genes to cancer cells via receptor-mediated endocytosis.

Ice template preparation yields pure nanoparticles by eliminating organic solvent contamination from conventional manufacturing processes.

Gold nanoparticles accumulate in injured vascular tissue to enable non-invasive optical detection via diffusion reflection measurements.

Tissuegenic implants utilize a growth-conductive matrix to support viable cell adhesion and migration within surgical repair applications.

Non-solvent extraction removes residual polymers from microparticles, achieving high purity without complex processing equipment.

Wet milling reduces pirfenidone particle size using water-based colloid mills, preventing explosion risk from dry milling thermal energy.

Bacterial cellulose networks provide yield stress for bead suspension while maintaining low viscosity and clarity in liquid detergents.

Cannabinoid formulation dissolved in propellants delivers active agents via metered dose inhaler without heating above 50°C.

Layer-by-layer chitosan-DNA nanoparticles silence CMIP in podocytes, preventing proteinuria while avoiding viral immune reactions.

Dialysis and lyophilization isolate extracellular vesicles into a stable powder, avoiding ultracentrifugation damage and cryoprotectant purity issues.

Formulations of single domain antigen binding molecules use lyoprotectants and buffers to prevent chemical degradation and aggregation during storage.

Artificial antigen presenting cells with MHC class II molecules stimulate and expand antigen-specific CD4+ T cells.

Biradical peptides with intrapeptide bonds cross the blood-brain barrier via active transport, delivering cargo while resisting serum degradation.

Pre-formulated enalapril powder eliminates dosage variability and contamination risks from crushing tablets.

A dry powder inhalation formulation combines tiotropium bromide, salmeterol xinafoate, and fluticasone propionate.

A grafted polyglutamic acid polymer protects interferon-beta from denaturation and aggregation.

A topical formulation combines 13-cis-retinoic acid, all-trans retinoic acid, and clindamycin to treat severe acne.

Sobrerol derivatives alleviate autoimmune neurological disease symptoms by administering specific compounds in controlled release dosage forms.

Roller compacted granules with controlled bulk density improve flowability and dissolution rates while masking chalky taste.

Pre-administering nutrition supplements modulates reticuloendothelial system activity to enhance nanotherapeutic agent bioavailability.

Monitoring Collagen-V and K-alpha 1 tubulin levels in patient exosomes allows clinicians to detect chronic rejection up to one year prior to symptom onset.

Low bloom fish gelatine replaces emulsifiers to eliminate air entrapment and chemical degradation in lutein microcapsules.

Amphiphilic polymer nanoparticles absorb near-infrared light to generate acoustic signals for deep tissue imaging applications.

A liquid mixture simulates N-vinylpyrrolidone copolymer dissolving properties to evaluate biologically active substance compatibility.

A biodegradable micro-bead embeds nano-beads to deliver therapeutic agents deep into tumor tissue.

Cyclic antibodies selectively bind toxic amyloid-beta oligomers, resolving the conflict between binding specificity and target plasticity.

Co-milling glycopyrronium bromide with an inhaled corticosteroid prevents particle aggregation, ensuring stable respirable fractions.

Metalloid chalcogen nanoparticles bind multiple radioisotopes intrinsically, eliminating transchelation risks and ensuring stable in vivo performance.

Covalently linked bioactive molecules on cell-permeable carriers enable precise genome editing while minimizing off-target effects.

Adjustable plasma communicates with a flowing liquid surface to synthesize nanoparticles of controlled size and shape.

Curcumin carbon quantum dots enhance antiviral activity through controlled thermal decomposition.

Sucrose and mannitol protect aluminum salt adjuvanted HPV vaccines from freezing damage, maintaining potency during lyophilization.

Segmented prime-and-trap vaccination accumulates resident memory T cells in the liver, overcoming sporozoite immunization effectiveness reduction.

Surface-modified silica nanoparticles with azoles resolve cytotoxicity trade-offs by inducing nuclear condensation and membrane disruption in cancer cells.

Self-assembling beta-casein micelles protect drugs from gastric acid degradation, enhancing bioavailability without complex manufacturing.

Amphiphilic bilirubin derivative shells encapsulate hydrophobic gas cores to form stable ultrasound contrast agents.

Segmented tongue-and-groove pre-closures prevent contamination by securing the capsule top before final sealing.

Conjugate alpha-hydroxyphosphonic acid with hydrophilic moieties to modify nanoparticle surfaces.

Elastin antibody-functionalized particles bind degraded elastic fibers, concentrating treatment compounds at target sites while reducing systemic toxicity.

Pyrrolopyrimidine nucleoside analogs penetrate cell membranes efficiently as phospholipid conjugates.